# US 2024/0198052 A1 · Fortified balloon inflation fluid for plasma system to disrupt vascular lesions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0198052 A1
- Document ID: US20240198052A1
- Status: Published application
- Kind: A1
- Application number: 18/589,076
- Filed: 2024-02-27
- Published: 2024-06-20
- Earliest claimed: 2019-06-26
- Assignees: Boston Scientific Scimed, Inc.
- Applicants: Boston Scientific Scimed, Inc.
- Inventors: Daniel Frank Massimini; Daniel Lee Krautkremer; Haiping Shao; Roger W. McGowan
- Web page: https://patentgrep.com/patent/US20240198052A1

## CPC

- A61M 25/0133: {Tip steering devices}
- A61B 17/22: Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
- A61B 18/245: {for removing obstructions in blood vessels or calculi}
- A61B 18/26: for producing a shock wave, e.g. laser lithotripsy
- A61L 27/20: Polysaccharides
- A61M 25/0009: {Making of catheters or other medical or surgical tubes}
- A61M 25/0155: {with hydraulic or pneumatic means, e.g. balloons or inflatable compartments}
- A61M 25/09: Guide wires
- A61B 2017/22062: {to be filled with liquid}
- A61B 2018/0022: {Balloons}
- A61B 2018/00285: {Balloons}
- A61B 2018/00345: {Vascular system}
- A61B 2018/00422: {Angioplasty}
- A61B 2018/2211: {Plurality of fibres}
- A61B 2018/2261: {with scattering, diffusion or dispersion of light}
- A61B 2018/2266: {with a lens, e.g. ball tipped}
- A61B 2018/2272: {with reflective or refractive surfaces for deflecting the beam (A61B2018/2261, A61B2018/2266 take precedence)}
- A61B 2018/2277: {with refractive surfaces}
- A61B 2018/2294: {with a diffraction grating}
- A61B 2018/263: {the conversion of laser energy into mechanical shockwaves taking place in a liquid}
- A61B 2018/266: {the conversion of laser energy into mechanical shockwaves taking place in a part of the probe}
- A61B 2090/306: {using optical fibres}
- A61L 2400/12: Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
- A61M 2025/09008: {having a balloon}
- A61M 2025/09183: {having tools at the distal tip}
- A61M 2202/0415: Plasma
- A61M 2205/3592: using telemetric means, e.g. radio or optical transmission
- A61M 2205/587: Lighting arrangements
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

A catheter system for imparting pressure to induce fractures at a treatment site within or adjacent a blood vessel wall includes a catheter, a fortified balloon inflation fluid and a first light guide. The catheter includes an elongate shaft and a balloon that is coupled to the elongate shaft. The balloon has a balloon wall and can expand to a first expanded configuration to anchor the catheter in position relative. The fortified balloon inflation fluid can expand the balloon to the first expanded configuration. The fortified balloon inflation fluid includes a base inflation fluid and a fortification component. The fortification component reduces a threshold for inducing plasma formation in the fortified balloon inflation fluid compared to the base inflation fluid. The fortification component can include at least one of carbon and iron. The first light guide is disposed along the elongate shaft and is positioned at least partially within the balloon. The first light guide is in optical communication with a light source and the fortified balloon inflation fluid. The light source provides sub-millisecond pulses of a light to the first light guide so that plasma formation and rapid bubble formation occur in the fortified balloon inflation fluid, thereby imparting pressure waves upon the treatment site.

## Claims

### Claim 1

A balloon catheter system comprising:
a catheter configured to advance to a treatment site, the catheter comprising an elongate shaft and a balloon that is coupled to the elongate shaft, the catheter defining an inflation fluid pathway including an inflation lumen and an interior of the balloon that are in fluid communication;
a inflation fluid fortification component disposed on a surface of the inflation fluid pathway, the inflation fluid fortification component including at least one of carbon and iron, and being configured to be mixed with a base inflation fluid introduced into the inflation fluid pathway to form a fortified balloon inflation fluid, the fortified balloon inflation fluid configured to reduce a threshold for inducing plasma formation in the fortified balloon inflation fluid compared to the base inflation fluid; and
a first energy guide that is disposed along the elongate shaft and is positioned at least partially within the balloon, the first energy guide being configured to be in communication with an energy source and including an end disposed within the balloon.

### Claim 2 (depends on 1)

The catheter system of claim 1, wherein the inflation fluid fortification component includes an iron dextran.

### Claim 3 (depends on 1)

The catheter system of claim 1, wherein the inflation fluid fortification component includes nanoparticles.

### Claim 4 (depends on 1)

The catheter system of claim 1, wherein the inflation fluid fortification component includes one of iron nanoparticles, gold nanoparticles, copper nanoparticles, carbon nanoparticles, carbon nanotubes, gold-coated carbon nanotubes and copper-coated carbon nanotubes.

### Claim 5 (depends on 1)

The catheter system of claim 1, wherein the base inflation fluid includes saline and contrast medium in a ratio of saline to contrast medium of from 25:75 volume percent to 75:25 volume percent.

### Claim 6 (depends on 1)

The catheter system claim 1, wherein the inflation fluid fortification component is configured to modify one of viscosity, density and surface tension of the fortified balloon inflation fluid compared to the base inflation fluid.

### Claim 7

A balloon catheter system comprising:
a catheter configured to advance to a treatment site, the catheter comprising an elongate shaft and a balloon that is coupled to the elongate shaft, the catheter defining an inflation fluid pathway including an inflation lumen and an interior of the balloon that are in fluid communication;
a fortified balloon inflation fluid disposed within the fluid pathway, the fortified inflation fluid comprising a base inflation fluid and fortification component including at least one of carbon and iron, the fortified balloon inflation fluid configured to reduce a threshold for inducing plasma formation in the fortified balloon inflation fluid compared to the base inflation fluid; and
a first energy guide that is disposed along the elongate shaft and is positioned at least partially within the balloon, the first energy guide being configured to be in communication with an energy source and including an end disposed within the balloon.

### Claim 8 (depends on 7)

The catheter system of claim 7, wherein the fortification component includes an iron dextran.

### Claim 9 (depends on 7)

The catheter system of claim 7, wherein the fortification component includes nanoparticles.

### Claim 10 (depends on 7)

The catheter system of claim 7, wherein the fortification component includes one of iron nanoparticles, gold nanoparticles, copper nanoparticles, carbon nanoparticles, carbon nanotubes, gold-coated carbon nanotubes and copper-coated carbon nanotubes.

### Claim 11 (depends on 7)

The catheter system of claim 7, wherein the base inflation fluid includes saline and contrast medium in a ratio of saline to contrast medium of from 25:75 volume percent to 75:25 volume percent.

### Claim 12 (depends on 7)

The catheter system claim 7, wherein the fortification component is configured to modify one of viscosity, density and surface tension of the fortified balloon inflation fluid compared to the base inflation fluid.

### Claim 13

A method for generating pressure waves to induce fractures at a treatment site within or adjacent a vessel wall of a blood vessel, the method comprising the steps of:
advancing a catheter to the treatment site within the blood vessel, the catheter comprising an elongate shaft, a balloon coupled to the elongate shaft, and an energy guide disposed along the elongate shaft so that the energy guide is positioned at least partially within the balloon;
expanding the balloon with a fortified balloon inflation fluid, the fortified balloon inflation fluid comprising a base inflation fluid and a fortification component, the fortified balloon inflation fluid being configured to reduce a threshold for inducing plasma formation in the fortified balloon inflation fluid compared to the base inflation fluid, wherein the fortification component includes one of carbon and iron; and
activating an energy source in communication with the energy guide and the fortified balloon inflation fluid to provide a pulses of energy from the energy source to the fortified balloon inflation fluid so that plasma formation occurs in the fortified balloon inflation fluid.

### Claim 14 (depends on 13)

The method of claim 13, wherein the fortification component comprises one of iron dextran and nanoparticles.

### Claim 15 (depends on 13)

The method of claim 13, wherein the fortification component comprises nanoparticles, the nanoparticles including one of iron nanoparticles, gold nanoparticles, copper nanoparticles, carbon nanoparticles, carbon nanotubes, gold-coated carbon nanotubes and copper-coated carbon nanotubes.

### Claim 16 (depends on 13)

The method of claim 13, wherein the first energy guide comprises an optical fiber and wherein the energy source comprises a laser.

### Claim 17 (depends on 13)

The method of claim 13, wherein the pulses of energy from the energy source are delivered at a frequency of between 1 Hz and 30 Hz.

### Claim 18 (depends on 13)

The method of claim 13, wherein the pulses of energy from the energy source are delivered at a frequency of between 30 Hz and 5000 Hz.

### Claim 19 (depends on 13)

The method of claim 13, wherein the step of expanding the balloon with the fortified balloon inflation fluid further comprises the steps of:
providing the fortification component as a coating disposed on an inside surface of a balloon wall or on the elongate shaft in fluid communication with the base inflation fluid,
providing the base inflation fluid to the balloon, and
the base inflation fluid solvating the fortification component coating to form the fortified balloon inflation fluid.

### Claim 20 (depends on 13)

The method of claim 13, wherein the base inflation fluid comprises saline and contrast medium in a ratio of saline to contrast medium of 25:75 volume percent to 75:25 volume percent.
